Assessing fatty acid biostatus: Red blood cells or plasma?

William S. Harris

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Omega-3 fatty acid (n-3 FA) biostatus can be estimated using red blood cell (RBC) membranes or plasma. The sample type that exhibits the lower within-person variability and is less affected by an acute dose of n-3 FA is preferred in clinical practice. The experiments described here indicate that RBC-based metrics are superior to plasma-based for use in patient care.

Original languageEnglish (US)
Pages (from-to)179-181
Number of pages3
JournalLipid Technology
Volume25
Issue number8
DOIs
StatePublished - Aug 1 2013

ASJC Scopus subject areas

  • Control and Systems Engineering
  • Food Science
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Assessing fatty acid biostatus: Red blood cells or plasma?'. Together they form a unique fingerprint.

  • Cite this